# A Study of AK130 in Patients With Advanced Malignant Tumors

> **NCT05653284** · PHASE1 · COMPLETED · sponsor: **Akeso** · enrollment: 19 (actual)

## Conditions studied

- Advanced Malignant Tumors

## Interventions

- **DRUG:** AK130

## Key facts

- **NCT ID:** NCT05653284
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-09
- **Primary completion:** 2023-12-12
- **Final completion:** 2024-05-30
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05653284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05653284, "A Study of AK130 in Patients With Advanced Malignant Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05653284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*